Abstract
The burden of diabetes in the elderly is becoming increasingly severe due to the aging population. Elderly patients with diabetes face unique challenges due to multiple comorbidities, atypical symptoms, an increased risk of hypoglycemia, and limited self-management capabilities. The Guidelines for the Management of Diabetes Mellitus in the Elderly in China (2024 Edition) advocate for a stratified, individualized approach that addresses the heterogeneous pathophysiologic profiles of these patients. Recent technological advances, including continuous glucose monitoring, smart insulin pens, needle-free injection systems, and new insulin pumps, have significantly improved glycemic management. The updated guidelines systematically review evidence-based recommendations for managing diabetes in the elderly, emphasizing the benefits of modern monitoring and insulin delivery technologies. This article interprets the updated guidelines with a focus on the technical principles, clinical benefits, and application dilemmas to ultimately improve long-term outcomes among elderly patients with diabetes.
Author supplied keywords
Cite
CITATION STYLE
Cai, Q., Zhao, P., Chen, X., Yu, S., Guo, L., & Pan, Q. (2025, October 1). New Technologies for Blood Glucose Management in Elderly Diabetics: An Interpretation of the Guidelines for the Management of Diabetes Mellitus in the Elderly in China (2024 Edition). Aging Medicine. John Wiley and Sons Inc. https://doi.org/10.1002/agm2.70044
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.